4.8 Article

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Journal

LANCET
Volume 376, Issue 9736, Pages 180-188

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)60588-0

Keywords

-

Funding

  1. Novartis
  2. Roche
  3. Amgen
  4. NIH/NHLBI [N01-HC-25195]
  5. American Heart Association
  6. US Department of Agriculture, Agricultural Research Service [58-1950-7-707]
  7. National Institute of Aging [AG14759]
  8. National Institute of Arthritis, Musculoskeletal, and Skin Diseases
  9. National Institute on Aging [R01 AR/AG 41398]
  10. Affymetrix Inc [N02-HL-6-4278]
  11. Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center
  12. Wellcome Trust
  13. Arthritis Research Campaign
  14. European Community [FP7/2007-2013, HEALTH-F2-2008-201865-GEFOS, 200800, OA /(FP7/2007-2013), HEALTH-F4-2007-201413, QLG2-CT-2002-01254]
  15. UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre
  16. Biotechnology and Biological Sciences Research Council [G20234]
  17. National Eye Institute (NEI) via an NIH/Center for Inherited Disease Research (CIDR)
  18. Netherlands Organization of Scientific Research (NWO) [175.010.2005.011, 911-03-012]
  19. Research Institute for Diseases in the Elderly [014-93-015: RIDE2]
  20. Netherlands Genomics Initiative/NWO [050-060-810]
  21. European Commission [HEALTH-F2-2008-201865-GEFOS, HEALTH-F2-2008-00-TREAT-OA]
  22. Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development
  23. Research Institute for Diseases in the Elderly
  24. Ministry of Education, Culture and Science
  25. Ministry for Health, Welfare and Sports
  26. European Commission
  27. Municipality of Rotterdam
  28. MRC [MC_U106188470, G0400546, G0000934, G0701863, G0600705, G0601653, MC_UP_A100_1003] Funding Source: UKRI
  29. Medical Research Council [MC_U106188470, MC_UP_A100_1003, MC_U106179471, G0801462, G0400546, G0000934, G0701863, G0400546B, MC_UP_A620_1014, G0601653, U1475000001, G0600705] Funding Source: researchfish
  30. National Institute for Health Research [PHCS/C4/4/016, NF-SI-0508-10275, NF-SI-0508-10082] Funding Source: researchfish

Ask authors/readers for more resources

Background Vitamin D is crucial for maintenance of musculoskeletal health, and might also have a role in extraskeletal tissues. Determinants of circulating 25-hydroxyvitamin D concentrations include sun exposure and diet, but high heritability suggests that genetic factors could also play a part. We aimed to identify common genetic variants affecting vitamin D concentrations and risk of insufficiency. Methods We undertook a genome-wide association study of 25-hydroxyvitamin D concentrations in 33 996 individuals of European descent from 15 cohorts. Five epidemiological cohorts were designated as discovery cohorts (n=16 125), five as in-silico replication cohorts (n=9367), and five as de-novo replication cohorts (n=8504). 25-hydroxyvitamin D concentrations were measured by radioimmunoassay, chemiluminescent assay, ELISA, or mass spectrometry. Vitamin D insufficiency was defined as concentrations lower than 75 nmol/L or 50 nmol/L. We combined results of genome-wide analyses across cohorts using Z-score-weighted meta-analysis. Genotype scores were constructed for confirmed variants. Findings Variants at three loci reached genome-wide significance in discovery cohorts for association with 25-hydroxyvitamin D concentrations, and were confirmed in replication cohorts: 4p12 (overall p=1.9x10(-109) for rs2282679, in GC); 11q12 (p=2.1x10(-22) for rs12785878, near DHCR7); and 11p15 (p=3.3x10(-20) for rs10741657, near CYP2R1). Variants at an additional locus (20q13, CYP24A1) were genome-wide significant in the pooled sample (p=6.0x10(-10) for rs6013897). Participants with a genotype score (combining the three confirmed variants) in the highest quartile were at increased risk of having 25-hydroxyvitamin D concentrations lower than 75 nmol/L (OR 2.47, 95% CI 2.20-2.78, p=2.3x10(-48)) or lower than 50 nmol/L (1.92, 1.70-2-16, p=1.0x10(-26)) compared with those in the lowest quartile. Interpretation Variants near genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status. Genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available